Clinical trial · Observational
Allergy Delabeling in Antibiotic Stewardship - Evaluations
Optimizing Antibiotic Selection in Hematologic Malignancy Patients With Reported Beta-lactam Allergy
NCT06967467CI-TRIAL-00113831RENEW-EVALenrolling by invitationClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this RENEW-EVAL project is to understand the potential barriers to implementation of the RENEW intervention into the routine clinical care of patients with a hematological malignancy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Beta Lactam Allergy in Patients With a Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ethnographic observation | Behavioral | — | UNRESOLVED |
| Semi-structured interview | Behavioral | — | UNRESOLVED |
| Survey | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Patients who enroll in the RENEW intervention
- description
- Patients who agree to actively participate in the RENEW intervention designed to identify opportunities to have the beta lactam allergy label removed from their electronic medical record.
- interventionNames
- Behavioral: Semi-structured interview
- Behavioral: Survey
- label
- Patients who decline enrollment in the RENEW intervention
- description
- Patients who were approached for enrollment in the RENEW intervention but declined consent.
- interventionNames
- Behavioral: Semi-structured interview
- label
- Clinicians
- description
- Clinicians who provide clinical care to patients enrolled in the intervention.
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patient participants: * a diagnosis of a hematologic malignancy (lymphoma, leukemia, myeloma) * a prior label applied to their medical record to indicate a beta lactam allergy * hospitalized as an inpatient to an oncology service at the time the study is conducted Clinician participants: * member of the primary inpatient care team Exclusion Criteria: Patient participants: * meet one of the exclusionary criteria for the RENEW clinical intervention Clinician participants: * no exclusions
References
Publications (0)
Data not yet available
No reference posted for this study.